G6PD GLUCOSE 6 PHOSPHATE DEHYDROGENASE - NEONATAL

G6PD GLUCOSE 6 PHOSPHATE DEHYDROGENASE - NEONATAL is a specialized diagnostic biochemical test designed to measure the activity of the G6PD enzyme in newborns. Glucose-6-phosphate dehydrogenase is an essential red blood cell enzyme that protects cells from oxidative stress. Deficiency of G6PD can lead to neonatal jaundice, acute hemolytic anemia, and severe complications when exposed to certain infections, foods, or medications.

Measurement of neonatal enzyme activity provides direct clinical insight into inherited metabolic and hematological health. Because early identification of G6PD deficiency supports timely pediatric and dietary management, specialized biochemical testing supplies essential clinical data for pediatrics, neonatology, hematology, and internal medicine evaluations.

The test requires a blood specimen collected by a qualified person using standard containers, followed by precise analysis using automated laboratory quantitative or qualitative enzymatic techniques. Results must always be interpreted in conjunction with the infant's clinical presentation, bilirubin levels, and pediatric history.

Benefits of G6PD GLUCOSE 6 PHOSPHATE DEHYDROGENASE - NEONATAL Testing

• Provides a direct measurement of G6PD enzyme activity in newborns.
• Helps diagnose G6PD deficiency and assess risks of neonatal jaundice and hemolytic anemia.
• Assists clinicians in pediatric and neonatology evaluations.
• Aids in supporting newborn screening programs for inherited enzyme disorders.
• Supports tracking of specialized pediatric care and trigger-avoidance plans.
• Complements bilirubin panels, complete blood counts (CBC), and neonatal evaluations.
• Utilizes precise laboratory enzymatic screening techniques for reliable results.
• Assists specialists in determining appropriate medical and pediatric management strategies.
• Provides dependable turnaround times to support specialized clinical care.
• Utilizes standard neonatal blood collection procedures.

Clinical Indications and Applications

Newborn Screening: The primary clinical indication is evaluating neonates presenting with prolonged jaundice, unexplained hemolysis, or family history of G6PD deficiency.

Clinical Assessment: The test is utilized when screening for inherited enzyme defects in specialized pediatric clinical settings.

Why Doctors Recommend This Test

Neonatologists, pediatricians, hematologists, and physicians recommend this test when investigating neonatal jaundice or screening newborns for inherited metabolic vulnerabilities. It delivers essential data required to guide safe clinical intervention.

Following proper blood collection guidelines will ensure a smooth and efficient testing procedure.

What Happens During The Procedure?

The collection procedure involves obtaining a small blood specimen from the newborn (often via heel prick or venous draw) by a qualified healthcare professional using standard collection containers under appropriate supervision protocols.

Once obtained, the sample is tested in the laboratory using advanced enzymatic assays to quantify G6PD activity. The procedure takes only a few minutes.

Normal Reporting Time

The report for the G6PD GLUCOSE 6 PHOSPHATE DEHYDROGENASE - NEONATAL test is generally available within 24 to 48 hours due to standard laboratory processing times. Results must be reviewed promptly with the referring pediatrician or specialist.

Who Should Consider This Test?

• Newborns evaluated for prolonged or severe jaundice in the first days of life.
• Infants investigated for inherited G6PD deficiency as directed by a clinician.

Understanding Test Results

Test results provide quantitative or qualitative measurements of G6PD enzyme activity, evaluated against established neonatal laboratory reference ranges.

Normal Findings: Normal enzyme activity indicates adequate G6PD function protecting red blood cells from oxidative stress.

Deficient Findings: Reduced enzyme activity indicates G6PD deficiency, requiring guidance on avoiding specific triggering medications, foods, and infections.

Clinical Limitations

Severe acute hemolysis or high reticulocyte counts can temporarily elevate G6PD activity levels, requiring clinical correlation or follow-up retesting.

ImportantSafety Information

Severe neonatal jaundice or acute pediatric symptoms require immediate medical attention. Patients must consult their healthcare provider or pediatrician to interpret newborn screening findings.